|
Some 60
people - CEOs, industry experts, patients and officials gathered at EuropaBio's Policy Forum on Advanced Therapies to hear what issues were
emerging in the Council discussions on this piece of legislation.
Click here for a
short report of this meeting.
The Policy
Forum tool is a way for EuropaBio to bring different stakeholders together to
discuss in an open and transparent way the issues that are important to
each other. The forum builds on the EuropaBio IIndustry
Hearing on Advanced Therapies that was held in November 2005.
For
further details contact, Adeline Farrelly
a.farrelly@europabio.org_____________
mmary Report
"Shaping
and paving the way for the next generation of biotech medicine to benefit
patients”
Slide Presentation
Wills
Hughes-Wilson -
Presentation
slides (pdf)
Chair of
EuropaBio Advanced
Therapies Working Group
The EuropaBio Policy Forum Programme
held 8 November 2006
Johan
Vanhemelrijck EuropaBio Secretary General
Andrea
Rappagliosi Chair of
EuropaBio Healthcare Council
Wills
Hughes-Wilson - Chair of
EuropaBio Advanced
Therapies Working Group
uarding the Core
of the Regulation:
Nicolas
Rossignol, DG
Enterprise, European Commission
Arto
Koho, Health
Attaché
Permanent Representation of Finland to the EU
Isabel de la
Mata,
Health
Counsellor, Spanish Permanent Representation to the EU
Frank
Niggemeier, Health
Counsellor, Permanent Representation of the Federal Republic
of Germany to the EU
Interactive
Session
Andrea
Rappagliosi Chair of
EuropaBio Healthcare Council
|
